Sidley Austin

Experts

17

Filter by: Practice area
Abi Twist
Associate
Sidley Austin
Ellen Pesch
Partner
Sidley Austin
Francesca Blythe
Sidley Austin
Katie Chin
Associate
Sidley Austin
Leonard Ng
Partner
Sidley Austin
Maria Isabel Manley
Sidley Austin
Martin Dowdall
Senior Managing Associate
Sidley Austin
Max Savoie
Partner
Sidley Austin
Monika Zdzieborska
Senior Managing Associate
Sidley Austin
Pamela Martinson
Sidley Austin
Rachpal Thind
Partner
Sidley Austin
Sara George
Sidley Austin
Sarah Lainchbury
Sidley Austin
Tanaan Quek
Managing Associate
Sidley Austin
Timothy Treanor
Partner
Sidley Austin
William Long
Sidley Austin
Zina Chatzidimitriadou
Associate
Sidley Austin
Contributions by Sidley Austin

3

Coronavirus (COVID-19)—regulatory implications for the UK and European life sciences industry [Archived]
Coronavirus (COVID-19)—regulatory implications for the UK and European life sciences industry [Archived]
Practice notes

This Practice Note has been archived and is not maintained. It discusses the regulatory implications of the coronavirus (COVID-19) pandemic for the UK and European life sciences industry. It provides guidance as to the response of UK and EU regulators in the areas of clinical trials, inspections and the continuity of supply in medicinal products and medical devices, as well as the postponement of implementation of the Medical Devices Regulation (MDR). It also summarises key research and development (R&D) initiatives at a UK and EU level and European Commission guidance on the collection and transfusion of convalescent COVID-19 plasma.

Payment Systems Regulator—duties and powers
Payment Systems Regulator—duties and powers
Practice notes

The Payment Systems Regulator (PSR) was established under the Financial Services (Banking Reform) Act 2013 (FS(BR)A 2013) and became fully operational in April 2015. This Practice Note provides further details of the Payment Systems Regulator’s statutory powers and duties under FS(BR)A 2013, as well as its concurrent competition powers under the Competition Act 1998 and Enterprise Act 2002.

Payment Systems Regulator—supervisory approach
Payment Systems Regulator—supervisory approach
Practice notes

The Payment Systems Regulator (PSR) was established under the Financial Services (Banking Reform) Act 2013 (FS(BR)A 2013) and became fully operational in April 2015. This Practice Note provides details of the PSR’s approach to supervising payment systems as set out in the PSR’s policy statement (PS 15/1) as well as its concurrent competition guidance and approach to monitoring and enforcing the assimilated Interchange Fee Regulation (Regulation (EU) 2015/751) (UK IFR). It also provides information on general and specific directions issued by the PSR, market reviews and super-complaints.

Contributions by Sidley Austin Experts

6

Conducting clinical research—data protection implications
Conducting clinical research—data protection implications
Practice notes

This Practice Note explores the data protection implications of conducting clinical research. In particular, this Practice Note considers the responsibility for data protection compliance in the context of clinical research, the relevant legal grounds for processing personal data for research purposes, transparency requirements, collaborative research and data sharing as well as exceptions to data subject rights when processing personal data in the context of research. Finally, this Practice Note provides a checklist of practical data protection considerations to bear in mind when planning research activities.

EEA passporting rights under the Mortgage Credit Directive
EEA passporting rights under the Mortgage Credit Directive
Practice notes

This Practice Note sets out the passporting rights and related notification requirements of mortgage credit intermediaries established in the European Economic Area set out in the Mortgage Credit Directive (MCD), which had been implemented by 21 March 2016. The Practice Note provides an overview of the MCD, the scope of passporting rights under the MCD, notification and consent requirements under the MCD and the supervisory processes that regulators and firms must follow.

ISDA 2021 Interest Rate Derivatives Definitions
ISDA 2021 Interest Rate Derivatives Definitions
Practice notes

This Practice Note covers what the ISDA 2021 Interest Rate Derivatives Definitions are and why they are used. It explores the key changes made to the 2006 ISDA Definitions and why these were deemed necessary as well as setting out what each section of the ISDA 2021 Interest Rate Derivatives Definitions cover.

mHealth—data protection considerations
mHealth—data protection considerations
Practice notes

Digital health developers, manufacturers and distributors of mobile health (mHealth) apps, and any connected software as medical devices (SaMD) or artificial intelligence (AI) system, must comply with significant data protection regulations in parallel with regulatory compliance throughout the life cycle of an app’s development and commercialisation to market. This Practice Note focuses on the data protection and privacy considerations for mHealth apps, devices or connected medical software (SaMD) in the UK and EEA. mHealth, like telehealth, is a subset of eHealth under the digital health umbrella and refers to the use of mobile applications to allow users to monitor, evaluate and improve their health using mobile devices. Further discussion addresses the more stringent protections required for health data referred to as ‘special category’ data or ‘sensitive’ personal data.

Regulation of consumer buy-to-let lending in the UK
Regulation of consumer buy-to-let lending in the UK
Practice notes

This Practice Note sets out the regulatory regime for consumer buy-to-let (CBTL) lending under the Mortgage Credit Directive Order 2015 (SI 2015/910) (MCD Order 2015), which transposed the EU Mortgage Credit Directive (2014/17/EU) (the MCD) into the UK regulatory framework prior to the UK’s decision to leave the EU. The regulated CBTL regime extended the regulated mortgage regime with respect to both secured (first or second charge) and unsecured forms of consumer credit agreements entered into on or after 21 March 2016 relating to property that in part, or in whole, is occupied as a dwelling on the basis of a rental agreement. This Practice Note also looks at the impact of the UK’s decision to leave the EU on the regulation of CBTL lending in the UK.

Other Work
Authorisation requirements for CBTL mortgages—flowchart
Authorisation requirements for CBTL mortgages—flowchart

The purpose of this flowchart is to assist firms in determining whether they need to apply for authorisation to carry on regulated activities in relation to consumer buy-to-let (CBTL) mortgages.

If you expected to see yourself on this page, click here.